A diverse group of people sitting in front of a computer
A diverse group of people sitting in front of a computer
  • 102-10
    Significant changes to the organization and its supply chain
  • 102-46
    Defining report content and topic Boundaries
  • 102-48
    Restatements of information
  • 102-49
    Changes in reporting
  • 102-50
    Reporting period
  • 102-51
    Date of most recent report
  • 102-52
    Reporting cycle
  • 102-53
    Contact point for questions regarding the report
  • 102-54
    Claims of reporting in accordance with GRI Standards
  • 102-56
    External assurance

Johnson & Johnson’s 2019 Health for Humanity Report (the Report) details our progress in sustainability. It is our primary source of annual disclosure on environment, social and governance (ESG) performance and should be reviewed in conjunction with disclosures on the ESG Policies & Positions page. Data in this Report cover the period between January 1, 2019, and December 31, 2019, unless otherwise indicated. Reporting on other matters specific to financial performance of the Company and its subsidiaries can be found in our 2019 Annual Report.

This Report covers Johnson & Johnson’s worldwide operations across our three business segments: Pharmaceutical, Medical Devices and Consumer Health. For select metrics, we report segment-level data. Contract manufacturers are excluded from the scope of this Report, unless otherwise noted.

The Report has been prepared in accordance with the Global Reporting Initiative (GRI) Standards: Core option. For the first time, it includes the Sustainability Accounting Standards Board (SASB) Index providing disclosures against relevant SASB Standards. The Report also serves as our annual United Nations Global Compact Communication on Progress.

The outcomes of our 2019 Priority Topics Assessment guided the Report’s structure and content.

ERM CVS conducted independent review and assurance of the following information and data in the Report (see independent assurance statements by ERM CVS.)

  • Progress against our Health for Humanity 2020 Goals, and associated data presented in the 2020 Goals Progress Scorecard.
  • Progress against United Nations Sustainable Development Goals (UN SDGs) commitments, and associated data presented in the UN SDGs Progress Scorecard.
  • Select year 2019 global greenhouse gas (GHG) emissions inventory, the percentage of electricity use generated by renewable energy sources, and NOx and SOx emissions (from combustion sources).

PricewaterhouseCoopers LLP (PwC) performed limited assurance on certain data in the following categories (see PwC's Report of Independent Accountants and Management's Assertion):

  • Contributions / Philanthropy
  • Diversity & Inclusion (select metrics)
  • Environmental Health & Safety (EH&S) Governance
  • Employee Retention and Turnover
  • Employee Safety (select metrics)
  • Product Quality (select metrics)

Our Corporate Internal Audit reviewed select data for accuracy, completeness and validity. The financial data and general information about the business in this Report were previously audited for disclosure in our 2019 Annual Report.

Acquisitions: EH&S data of recently acquired companies, except for employee road safety data and site ISO and OHSAS certification data, are included in the Report two years after acquisition, unless otherwise noted. This grace period allows the new acquisitions to adjust their EH&S management and reporting systems to Johnson & Johnson standards. Road safety data are integrated the first year after acquisition, where available, and two years after acquisition at the latest. ISO and OHSAS certification data are integrated three years after acquisition. The dates and details of recent acquisitions can be found in Note 20 (Business Combinations and Divestitures) on page 80 of our 2019 Annual Report.

Divestitures: Except for injury statistics and violations or fines, EH&S data of divested companies are excluded in the reporting year.

Restatements: We use a 5% change threshold to apply to significant changes in data or information that is restated, unless otherwise noted. There are a number of potential reasons that may lead to a restatement of either prior periods or baseline data (e.g. a significant change in newly published measures, new acquisitions or divestitures, data errors, or improvements in data collection methodology over time). Depending on circumstances, each is evaluated using this threshold, and appropriate disclosures are included in the Report. Data that were not disclosed in prior years are noted as “not reported” in relevant tables throughout the Report.

Human Resources Data: These data are based on headcount data from Human Resources Information Systems (HRIS). HRIS headcount methodology differs from that used for the headcount in our Annual Report/Form 10-K, which is based on the number of full-time equivalent positions (FTE). HRIS data exclude employees on long-term disability. Data may not include full population from more recently acquired companies.

We welcome your queries and feedback on this Report. Please contact us at:

You are leaving jnj.com and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.